SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-460561
Filing Date
2012-11-08
Accepted
2012-11-08 16:34:13
Documents
13
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398351d10q.htm 10-Q 507408
2 EX-10.1 d398351dex101.htm EX-10.1 61181
3 EX-10.2 d398351dex102.htm EX-10.2 192723
4 EX-31.1 d398351dex311.htm EX-31.1 10175
5 EX-31.2 d398351dex312.htm EX-31.2 10239
6 EX-32.1 d398351dex321.htm EX-32.1 4015
7 EX-32.2 d398351dex322.htm EX-32.2 4046
  Complete submission text file 0001193125-12-460561.txt   3029162

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT achn-20120930.xml EX-101.INS 299436
9 XBRL TAXONOMY EXTENSION SCHEMA achn-20120930.xsd EX-101.SCH 27719
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achn-20120930_cal.xml EX-101.CAL 43595
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achn-20120930_def.xml EX-101.DEF 77075
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE achn-20120930_lab.xml EX-101.LAB 220160
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achn-20120930_pre.xml EX-101.PRE 164986
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33095 | Film No.: 121190488
SIC: 2834 Pharmaceutical Preparations